Showing 1 - 18 of 18 trials – Showing only trials currently accepting patients

• Neuropsychological and Behavioral Testing in Younger Patients With Cancer

  Stanford is currently accepting patients for this trial.

• A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)

  Stanford is currently accepting patients for this trial.

• Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma

  Stanford is currently accepting patients for this trial.

• [18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers

  Stanford is currently accepting patients for this trial.

• Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

  Stanford is currently accepting patients for this trial.

• A Study of Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors

  Stanford is currently accepting patients for this trial.

• Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors

  Stanford is currently accepting patients for this trial.

• Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma

  Stanford is currently accepting patients for this trial.

• Volitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors

  Stanford is currently accepting patients for this trial.

• Dose Escalation Study of CLR 131 in Children, Adolescents, and Young Adults With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma

  Stanford is currently accepting patients for this trial.

• Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma

  Stanford is currently accepting patients for this trial.

• Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma

  Stanford is currently accepting patients for this trial.

• Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM

  Stanford is currently accepting patients for this trial.

• A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma

  Stanford is currently accepting patients for this trial.

• A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

  Stanford is currently accepting patients for this trial.

• Safety of ABM-1310 in Patients With Advanced Solid Tumors

  Stanford is currently accepting patients for this trial.

• Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study)

  Stanford is currently accepting patients for this trial.

• Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors

  Stanford is currently accepting patients for this trial.